Scholtz & Company’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-87,975
Closed -$2.71M 77
2021
Q2
$2.71M Buy
87,975
+2,930
+3% +$87.7K 0.93% 36
2021
Q1
$2.18M Buy
85,045
+69,045
+432% +$1.73M 0.83% 35
2020
Q4
$256K Buy
+16,000
New +$197K 0.1% 70

Other funds holding RNLX

Scholtz & Company's RNLX Position: Q3 2021 in Review

Scholtz & Company sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 87,975 shares — an estimated $2.71M sold.

Scholtz & Company first reported a position in RNLX in Q4 2020 and held it in 3 quarters. The position peaked at $2.71M in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.

  • Scholtz & Company reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Scholtz & Company sold 87,975 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $2.71M.
  • Scholtz & Company first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
  • Scholtz & Company's Renalytix plc American Depositary Shares position peaked at $2.71M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.

Based on Scholtz & Company's 13F filing for Q3 2021, filed 15 Nov 2021.